GRPM Among Mid Cap ETFs
End-of-day Nov 18, 2026 · 88 Mid cap ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −3.4% | −1.0% | −1.1% | +18.4% | +24.3% | +68.6% | +52.8% | +208.0% | +473.8% |
| Peer average | +0.3% | −3.6% | −1.7% | −4.9% | +9.9% | +15.8% | +56.9% | +35.7% | +187.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$33 of every $1,000 in GRPM is Abercrombie
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ANFAbercrombie & Fitch | Consumer Cyclical | 3.28% | $328.26 | 137K | $19.6M |
| 2 | DUOLDuolingo | Technology | 3.10% | $310.08 | 116K | $18.5M |
| 3 | SNSharkNinja | Consumer Cyclical | 2.80% | $280.04 | 76K | $16.7M |
| 4 | PCTYPaylocity | Technology | 2.74% | $274.09 | 92K | $16.4M |
| 5 | KNSLKinsale Capital Group | Financial Services | 2.56% | $256.16 | 39K | $15.3M |
| 6 | HALOHalozyme Therapeutics | Healthcare | 2.55% | $254.70 | 159K | $15.2M |
| 7 | RNRRenaissanceRe | Financial Services | 2.54% | $253.69 | 43K | $15.2M |
| 8 | APPFAppfolio | Technology | 2.48% | $247.92 | 70K | $14.8M |
| 9 | MEDPMedpace | Healthcare | 2.47% | $246.64 | 23K | $14.7M |
| 10 | EXELExelixis | Healthcare | 2.36% | $236.15 | 206K | $14.1M |
| 11 | THCTenet Healthcare | Healthcare | 2.29% | $229.30 | 49K | $13.7M |
| 12 | DOCUDocusign | Technology | 2.29% | $228.50 | 180K | $13.7M |
| 13 | IDCCInterDigital | Technology | 2.24% | $224.35 | 49K | $13.4M |
| 14 | MANHManhattan Associates | Technology | 2.15% | $215.20 | 51K | $12.9M |
| 15 | DOCSDoximity | Healthcare | 2.14% | $213.76 | 411K | $12.8M |
of the $520B in 108 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ANF | Abercrombie & Fitch | 3.28% |
| 2 | DUOL | Duolingo | 3.10% |
| 3 | SN | SharkNinja | 2.80% |
| 4 | PCTY | Paylocity | 2.74% |
| 5 | KNSL | Kinsale Capital Group | 2.56% |
| 6 | HALO | Halozyme Therapeutics | 2.55% |
| 7 | RNR | RenaissanceRe | 2.54% |
| 8 | APPF | Appfolio | 2.48% |
| 9 | MEDP | Medpace | 2.47% |
| 10 | EXEL | Exelixis | 2.36% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.15 |
| Jun 22, 2026 | Jun 26, 2026 | $0.20 |
| Mar 23, 2026 | Mar 27, 2026 | $0.21 |
| Dec 22, 2025 | Dec 26, 2025 | $0.22 |
| Sep 22, 2025 | Sep 26, 2025 | $0.32 |
| Jun 23, 2025 | Jun 27, 2025 | $0.49 |
| Mar 24, 2025 | Mar 28, 2025 | $0.41 |
| Dec 23, 2024 | Dec 27, 2024 | $0.21 |
| Sep 23, 2024 | Sep 27, 2024 | $0.29 |
| Jun 24, 2024 | Jun 28, 2024 | $0.30 |
| Mar 18, 2024 | Mar 22, 2024 | $0.28 |
| Dec 18, 2023 | Dec 22, 2023 | $0.19 |